A combination of two previously studied osteoarthritis drugs reverses arthritis in rats

The top image shows a knee joint in a healthy rat. (White indicates cartilage.) The second image from top shows a joint with grade 2 untreated osteoarthritis. The third image shows a joint with osteoarthritis that has worsened from grade 2 to grade 4 after six weeks of placebo therapy. The bottom image shows a joint with osteoarthritis that improved from grade 2 to grade 1 (mild) after six weeks of combination therapy with alphaKlotho and sTGFbR2.

Credit: Salk Institute

Article Highlights

People with osteoarthritis, or “wear and tear” arthritis, have limited treatment options: pain relievers or joint replacement surgery. Now, Salk researchers have discovered that a powerful combination of two experimental drugs reverses the cellular and molecular signs of osteoarthritis in rats as well as in isolated human cartilage cells
“What’s really exciting is that this is potentially a therapy that can be translated to the clinic quite easily,” says Juan Carlos Izpisua Belmonte, lead author and a professor in Salk’s Gene Expression Laboratory. “We are excited to continue refining this promising combination therapy for human use.”
Affecting 30 million adults, osteoarthritis is the most common joint disorder in the United States and its prevalence is expected to rise in coming years due to the aging population and increasing rate of obesity. The disease is caused by gradual changes to cartilage that cushions bones and joints. During aging and repetitive stress, molecules and genes in the cells of this articular cartilage change, eventually leading to the breakdown of the cartilage and the overgrowth of underlying bone, causing chronic pain and stiffness
The researchers treated young, otherwise healthy rats with osteoarthritis with viral particles containing the DNA instructions for making αKLOTHO and TGFβR2
Six weeks after the treatment, rats that had received control particles had more severe osteoarthritis in their knees, with the disease progressing from stage 2 to stage 4. However, rats that had received particles containing αKLOTHO and TGFβR2 DNA showed recovery of their cartilage: the cartilage was thicker, fewer cells were dying, and actively proliferating cells were present. These animals’ disease improved from stage 2 to stage 1, a mild form of osteoarthritis, and no negative side effects were observed
“From the very first time we tested this drug combination on just a few animals, we saw a huge improvement,” says Isabel Guillen-Guillen, also a Salk postdoctoral fellow and the paper’s co-first author. “We kept checking more animals and seeing the same encouraging results.”
“We think that this could be a viable treatment for osteoarthritis in humans,” says Pedro Guillen, director of the Clinica CEMTRO and co-corresponding author

The Complete Story: DRUG COMBO REVERSES ARTHRITIS IN RATS

Salk Institute for Biological Studies | Harvard University | Universidad Católica San Antonio de Murcia | Chinese Academy of Sciences

Go deeper with Bing News on:

Osteoarthritis

Global Osteoarthritis Pain Drugs Market 2020 Industry Outlook, Classification, Demand, Regional Analysis and Forecast to 2025
on January 19, 2021 at 10:42 am
Global Osteoarthritis Pain Drugs Market 2020 by Manufacturers, Type and Application, Forecast to 2025 is the latest market report rolled out by MarketsandResearch.biz, presents an encyclopedic ...
Primary Care Physicians 'Generally' Good Gatekeepers for Low-Value Services, Study Finds
on January 19, 2021 at 6:04 am
The researchers reviewed utilization of low-value services such as imaging for non-specific back pain and arthroscopic surgery for knee osteoarthritis.
Osteoarthritis Treatment Market Size, Share 2020 Industry Growing Rapidly with Recent Demand, Trends, Development, Revenue and Forecast to 2025
on January 19, 2021 at 2:18 am
The growth of the global osteoarthritis treatment market is due to the rising geriatric population, increasing incidence of osteoarthritis, and rising demand for minimally invasive surgical procedures ...
The Best Shoes for Knee Arthritis May Be Stiff, Stable and Cushioned Ones
on January 19, 2021 at 2:00 am
People with knee arthritis were less likely to report pain and stiffness if they wore stable, supportive shoes, versus flat-soled, flexible ones.
Nanoparticle injections into arthritic knees could slow cartilage loss
on January 18, 2021 at 6:25 pm
Osteoarthritis is a painful, debilitating and fairly common condition that’s hard to slow or stop, so treatment options are mostly limited to reducing pain. But a new study in mice has now found that ...

Go deeper with Google Headlines on:

Osteoarthritis

Pathophysiology of Osteoarthritis: Changes in Cartilage, Bone, and More - Verywell Health
January 5, 2021
Knee injection shows promise as osteoarthritis treatment in mice - Drug Target Review
January 18, 2021
These Are the Early Signs of Osteoarthritis - HealthCentral.com
December 21, 2020
The Best Shoes for Knee Arthritis - The New York Times
January 19, 2021
Natural Remedies for Osteoarthritis - HealthCentral.com
January 14, 2021

Go deeper with Bing News on:

Reversing osteoarthritis

5 Tips to Minimize Rheumatoid Arthritis Flare-Ups, According to an Expert
on January 14, 2021 at 1:17 pm
Some mornings, it was such a struggle to get out of bed and dress herself, the New Jersey-based home healthcare nurse had to call out of work. A few years after the diagnosis, Tara is managing her ...
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For ...
on January 12, 2021 at 1:43 am
RMAT Designation Enables Closer FDA Interactions to Support Accelerated Approval CANTON, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative ...
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
on January 11, 2021 at 6:22 am
FDA Determines ReNu Preliminary Clinical Evidence Indicates Potential to Address Unmet Medical Needs for the Management of Symptoms Associated ...
Joint Pain Injections Market: Increasing Geriatric Population and Unmet Clinical Needs in Patients with Joint Pain Projected to Boost the Market
on January 11, 2021 at 3:47 am
Transparency Market Research (TMR) has published a new report titled, “Joint Pain Injections Market - Global Industry Analysis, Size, Share, Growth, ...
Coronavirus: US smashes record with more than 300,000 daily cases — as it happened
on January 9, 2021 at 1:20 pm
London has highest proportion of positive tests in England. US economy sheds jobs for first time since April. German industrial output and exports show resilience.